MedTrace Logo

The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty

NCT02504125 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-03-04

No results posted yet for this study

Summary

A randomized, double-blind, single-center and controlled study comparing the efficacy and safety of intravenous administration of tranexamic acid to reduce blood loss in simultaneous bilateral total knee arthroplasty.

Conditions

  • Blood Loss

Interventions

DRUG

Tranexamic Acid

1 g of tranexamic acid in 100 mL of normal saline intravenously approximately 15 minutes before incision

DRUG

Normal saline

100 mL of normal saline intravenously approximately 15 minutes before incision

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Jinyu Zhu, M.D. · Department of Orthropaedics, Xijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-06-30
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02504125 on ClinicalTrials.gov